Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
K PharmaTSE:4896 -0.55%12 10-Year ROIIC % is 0.00 as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 1,104 Biotechnology companies, K Pharma ranks worse than 90579.62% on this metric.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
K Pharma does not have enough data to calculate 10-Year ROIIC %.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
K Pharma 10-Year ROIIC % Related Terms
K Pharma 10-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for K Pharma's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4896 vs VRTX, REGN, RVMD: 10-Year ROIIC % Comparison
For the Biotechnology subindustry, K Pharma's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
K Pharma 10-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, K Pharma's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where K Pharma's 10-Year ROIIC % falls into.
K Pharma's 10-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
10-Year ROIIC %
=
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( -916.056 (Dec. 2025) - (Dec. 2015) )
/
( 121.959 (Dec. 2025) - (Dec. 2015) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
K Pharma (TSE:4896) has a 10-Year ROIIC % of 0.00 as of Dec. 2025. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on K Pharma and its competitors. According to the industry distribution chart, K Pharma ranks #999999 out of 1104 companies in the Biotechnology industry.
Is K Pharma's 10-Year ROIIC % too high?
K Pharma's current 10-Year ROIIC % is 0.00. Based on the distribution chart, K Pharma ranks #999999 out of 1104 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, K Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's 10-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, K Pharma ranks #999999 out of 1104 companies for 10-Year ROIIC %. This places K Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for a Biotechnology company?
A good 10-Year ROIIC % depends on the Biotechnology industry context. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on K Pharma and its competitors. K Pharma's current 10-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current 10-Year ROIIC % of 0.00. The current 10-Year ROIIC % is 0.00. K Pharma's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For K Pharma (TSE:4896), the current 10-Year ROIIC % is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
12GF Score
Get the complete analysis for TSE:4896
10-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4896 has been successfully added to your 
